v3 Template
C

Cellvie

Biotechnology/Healthcare ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$5.5M
Funding Rounds
1
Last Funding
2023-02-06

About Cellvie

cellvie Inc. is pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach targeting cellular energy metabolism. The company derives medicines from cells, leveraging mitochondria, a cornerstone of evolution, to address health, disease, and aging. Their mission is to reinvigorate cell energy metabolism and introduce a new category of medicines.

Products & Services

Therapeutic Mitochondria Transplantation:A treatment modality aimed at augmenting and replacing failing mitochondria to restore cellular energy metabolism, with initial application in ischemia-reperfusion injury, particularly kidney transplantation.

Specialties

Therapeutic Mitochondria Transplantation Cellular Energy Metabolism Ischemia-Reperfusion Injury Treatment Kidney Transplantation Solutions Aging and Degenerative Disease Research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Additional Funding
T: -
FT: Additional Funding 		A: 5500000
MR: -
FA: $5.5M
FAN: 5500000 		D: 2023-02-06
FD: 2023-02-06 		2 investors
Additional Funding Latest
2023-02-06
$5.5M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Alex Schueller

Repeat-Entrepreneur in Life Sciences

J

James McCully

World-leading expert in mitochondria biology and cardioprotection

P

Pedro del Nido

Pediatric Cardiac Surgeon

S

Sitaram Emani

Cardiothoracic Pediatric Surgeon

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Cellvie Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~40 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro